Nurul Asma Abdullah (68 results)

Condition: New. In English.

Condition: New.

Taschenbuch. Condition: Neu. Malaria Vaccine Development | A Recombinant BCG-Based Vaccine Expressing Blood-Stage Antigen of P. Falciparum | Nurul Asma Abdullah (u. a.) | Taschenbuch | 180 S. | Englisch | 2011 | LAP LAMBERT Academic Publishing | EAN 9783844304862 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. …

Condition: Neu. Edited by Wan Safwani Wan Kamarul Zaman and Nurul asma Abdullah. XVII,499 Seiten mit zahlreichen Farb- und s/w-Abb. sowie Tabellen, gebunden (Springer-Verlag 2023). Gewicht: 938 g - Gebunden/Gebundene Ausgabe.

Condition: New.

Taschenbuch. Condition: Neu. Sustainable Material for Biomedical Engineering Application | Wan Safwani Wan Kamarul Zaman (u. a.) | Taschenbuch | xvii | Englisch | 2024 | Springer | EAN 9789819922697 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. …

Condition: As New. Unread book in perfect condition.

Condition: New.

Condition: New. In English.

Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Sustainable Material for Biomedical Engineering Application discusses current interdisciplinary approaches in the development of materials and their derivatives that are sustainable for biomedical engineering application. Recent advancement of materials research has shown to have great impact on biomedical and clinical applications. With potential for sustainability, the materials discussed and illustrated in this book, may have the ability to increase and contribute to wider therapeutic options for patients. On the other hand, with the advancement in materials technology, they also have positive impacts in terms of reproducibility and more cost-effective manufacturing solutions for biomedical engineering industry. Some of the main aspects covered in this book are utilisation of human waste, food waste and green technology approach for materials in biomedical engineering applications such as tissue engineering, 3D printing and biosensing. A team of experts from various disciplines share recent advances that provide details and integrates different approaches to sustainable materials development. This book is intended for academicians, researchers, students and industrial players in the field of materials and biomedical engineering.…

Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Sustainable Material for Biomedical Engineering Application discusses current interdisciplinary approaches in the development of materials and their derivatives that are sustainable for biomedical engineering application. Recent advancement of materials research has shown to have great impact on biomedical and clinical applications. With potential for sustainability, the materials discussed and illustrated in this book, may have the ability to increase and contribute to wider therapeutic options for patients. On the other hand, with the advancement in materials technology, they also have positive impacts in terms of reproducibility and more cost-effective manufacturing solutions for biomedical engineering industry. Some of the main aspects covered in this book are utilisation of human waste, food waste and green technology approach for materials in biomedical engineering applications such as tissue engineering, 3D printing and biosensing. A team of experts from various disciplines share recent advances that provide details and integrates different approaches to sustainable materials development. This book is intended for academicians, researchers, students and industrial players in the field of materials and biomedical engineering. …

Condition: New. 2023rd edition NO-PA16APR2015-KAP.

Condition: New. 1st ed. 2023 edition NO-PA16APR2015-KAP.

Condition: New. Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.…

Hardcover. Condition: Brand New. 516 pages. 9.25x6.10x9.21 inches. In Stock.

Condition: gut. 2023. Sustainable Material for Biomedical Engineering Application In deutscher Sprache. pages.

Condition: New.

Condition: New.

Condition: New.

Condition: New.

Condition: New.

Taschenbuch. Condition: Neu. Entwicklung von Malaria-Impfstoffen | Ein rekombinanter Impfstoff auf BCG-Basis, der das Antigen im Blutstadium von P. Falciparum exprimiert | Nurul Asma Abdullah | Taschenbuch | 184 S. | Deutsch | 2021 | Verlag Unser Wissen | EAN 9786202759342 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu.…

Condition: Hervorragend. Zustand: Hervorragend | Sprache: Deutsch | Produktart: Bücher | Die Impfstoffentwicklung gegen Antigene im Blutstadium zielt darauf ab, inhibitorische Antikörper gegen die zirkulierenden Merozoiten zu induzieren und so zu verhindern, dass diese rote Blutkörperchen infizieren. Ein solcher Kandidat für das Blutstadium ist der 19 kDa C-Terminus des Merozoiten-Oberflächenproteins-1 (MSP-1C). Es wurde gezeigt, dass MSP-1C sowohl inhibitorische als auch blockierende Antikörper induziert, wobei letztere die Schutzwirkung der ersteren blockieren. Inhibitorische Antikörper binden an MSP-1C und hemmen die Merozoiteninvasion roter Blutkörperchen, aber die Bindung blockierender Antikörper kann die Bindung inhibitorischer Antikörper verhindern, wodurch der Parasit in einen Erythrozyten eindringen kann. Dieses Buch enthält einige Informationen zur Entwicklung eines Malaria-Impfstoffs im Blutstadium, der auf einer mutierten Version von MSP-1C basiert und inhibitorische Antikörper gegen Malariaparasiten induziert. Die Verwendung von lebendem rekombinantem Mycobacterium bovis bacille Calmette Guerin als Impfstoffvehikel wurde ebenfalls in diesem Buch beschrieben. Es wurde gefunden, dass das rBCG, das die mutierte Version von MSP-1C exprimiert, ein gewisses Maß an Schutz gegen P. falciparum induziert; Dies ebnet den Weg für die rationelle Verwendung von rBCG als Malaria-Impfstoffkandidat im Blutstadium.…

Softcover. Condition: gut. 2021. Entwicklung von Malaria-Impfstoffen In deutscher Sprache. pages.

Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -El desarrollo de vacunas contra los antígenos en estadio sanguíneo tiene como objetivo inducir anticuerpos inhibidores hacia los merozoitos circulantes, evitando así que infecten los glóbulos rojos. Uno de estos candidatos al estadio sanguíneo es el extremo C-terminal de 19 kDa de la proteína 1 de superficie del merozoito (MSP-1C). Se ha demostrado que la MSP-1C induce tanto anticuerpos inhibidores como bloqueadores, bloqueando los últimos los efectos protectores del primero. Los anticuerpos inhibidores se unirán a MSP-1C e inhibirán la invasión de glóbulos rojos por merozoitos, pero la unión de anticuerpos bloqueantes puede prevenir la unión de anticuerpos inhibidores permitiendo así que el parásito invada un eritrocito. Este libro proporciona información sobre el desarrollo de la vacuna contra la malaria en etapa sanguínea basada en la versión mutada de MSP-1C que induce anticuerpos inhibidores contra el parásito de la malaria. En este libro también se describió el uso de Mycobacterium bovis bacilo de Calmette Guerin recombinante vivo como vehículo de vacuna. Se encontró que el rBCG que expresa la versión mutada de MSP-1C induce cierto nivel de protección contra P. falciparum; así allanando el camino para el uso racional de rBCG como candidato a vacuna contra la malaria en estadio sanguíneo. 184 pp. Spanisch.…

Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Vaccine development against blood-stage antigens is aimed at inducing inhibitory antibodies towards the circulating merozoites, thus preventing them from infecting red blood cells. One such blood stage candidate is the 19 kDa C-terminus of merozoite surface protein-1 (MSP-1C). MSP-1C has been shown to induce both inhibitory as well as blocking antibodies, the latter blocking the protective effects of the former. Inhibitory antibodies will bind to MSP-1C and inhibit merozoite invasion of red blood cell but the binding of blocking antibodies can prevent binding of inhibitory antibodies thereby allowing the parasite to invade an erythrocyte. This book provides some information regarding the development of blood-stage malaria vaccine based on mutated version of MSP-1C which induces inhibitory antibodies against malarial parasite. The use of live recombinant Mycobacterium bovis bacille Calmette Guerin as a vaccine vehicle was also described in this book. The rBCG expressing the mutated version of MSP-1C was found to induce some level of protections against P. falciparum; thus paving the way for the rational use of rBCG as a blood-stage malaria vaccine candidate. 180 pp. Englisch.…

Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Vaccine development against blood-stage antigens is aimed at inducing inhibitory antibodies towards the circulating merozoites, thus preventing them from infecting red blood cells. One such blood stage candidate is the 19 kDa C-terminus of merozoite surface protein-1 (MSP-1C). MSP-1C has been shown to induce both inhibitory as well as blocking antibodies, the latter blocking the protective effects of the former. Inhibitory antibodies will bind to MSP-1C and inhibit merozoite invasion of red blood cell but the binding of blocking antibodies can prevent binding of inhibitory antibodies thereby allowing the parasite to invade an erythrocyte. This book provides some information regarding the development of blood-stage malaria vaccine based on mutated version of MSP-1C which induces inhibitory antibodies against malarial parasite. The use of live recombinant Mycobacterium bovis bacille Calmette Guerin as a vaccine vehicle was also described in this book. The rBCG expressing the mutated version of MSP-1C was found to induce some level of protections against P. falciparum; thus paving the way for the rational use of rBCG as a blood-stage malaria vaccine candidate.…

Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Abdullah Nurul AsmaNurul Asma Abdullah, BSc (HON), PhD Lecturer of Microbiology and Immunology at Universiti Sains Malaysia, Malaysia. Norazmi Mohd Nor, BSc (HON), PhD Professor in Molecular Immunology at Universiti Sains Malaysia.…

Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Le développement de vaccins contre les antigènes du stade sanguin vise à induire des anticorps inhibiteurs contre les mérozoïtes circulants, les empêchant ainsi d'infecter les globules rouges. Un tel candidat au stade sanguin est l'extrémité C-terminale de 19 kDa de la protéine de surface 1 du mérozoite (MSP-1C). Il a été démontré que la MSP-1C induisait à la fois des anticorps inhibiteurs et bloquants, ces derniers bloquant les effets protecteurs des premiers. Les anticorps inhibiteurs se lieront à la MSP-1C et inhiberont l'invasion des mérozoïtes des globules rouges, mais la liaison des anticorps bloquants peut empêcher la liaison des anticorps inhibiteurs, permettant ainsi au parasite d'envahir un érythrocyte. Ce livre fournit des informations concernant le développement d'un vaccin contre le paludisme au stade sanguin basé sur une version mutée de MSP-1C qui induit des anticorps inhibiteurs contre le parasite du paludisme. L'utilisation de Mycobacterium bovis bacille vivante recombinante Calmette Guerin comme véhicule vaccinal a également été décrite dans cet ouvrage. Le rBCG exprimant la version mutée de MSP-1C s'est avéré induire un certain niveau de protection contre P. falciparum; ouvrant ainsi la voie à l'utilisation rationnelle du rBCG comme candidat vaccin contre le paludisme au stade sanguin. 184 pp. Französisch.…

Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - El desarrollo de vacunas contra los antígenos en estadio sanguíneo tiene como objetivo inducir anticuerpos inhibidores hacia los merozoitos circulantes, evitando así que infecten los glóbulos rojos. Uno de estos candidatos al estadio sanguíneo es el extremo C-terminal de 19 kDa de la proteína 1 de superficie del merozoito (MSP-1C). Se ha demostrado que la MSP-1C induce tanto anticuerpos inhibidores como bloqueadores, bloqueando los últimos los efectos protectores del primero. Los anticuerpos inhibidores se unirán a MSP-1C e inhibirán la invasión de glóbulos rojos por merozoitos, pero la unión de anticuerpos bloqueantes puede prevenir la unión de anticuerpos inhibidores permitiendo así que el parásito invada un eritrocito. Este libro proporciona información sobre el desarrollo de la vacuna contra la malaria en etapa sanguínea basada en la versión mutada de MSP-1C que induce anticuerpos inhibidores contra el parásito de la malaria. En este libro también se describió el uso de Mycobacterium bovis bacilo de Calmette Guerin recombinante vivo como vehículo de vacuna. Se encontró que el rBCG que expresa la versión mutada de MSP-1C induce cierto nivel de protección contra P. falciparum; así allanando el camino para el uso racional de rBCG como candidato a vacuna contra la malaria en estadio sanguíneo.…